Study #2024-1383
EXCLAIM: exploring combined local and systemic approaches In brain metastasis: a multi-cohort randomized phase II study evaluating initial response to systemic therapy and subsequent integration of stereotactic radiosurgery in patients with low-risk brain metastases and central nervous system-active systemic therapy options
MD Anderson Study Status
Enrolling
Treatment Agent
Description
To learn if consolidative stereotactic radiosurgery (cSRS) can help to control central nervous system (CNS) disease in patients who have brain metastases and have a partial response or stable brain metastases after systemic therapy. To learn if using SRS to treat all brain metastases that do not respond to systemic therapy versus treating only metastases that are getting worse can help to control CNS disease in patients whose disease gets worse after systemic therapy.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Brain Metastases
Study phase:
Phase II
Physician name:
Thomas Beckham
Department:
Radiation Oncology
For general questions about clinical trials:
1-844-227-7897
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.